Keyphrases
Cytotoxicity
100%
Oleic Acid
100%
Paclitaxel
100%
γ-linolenic Acid
100%
Human Breast Cancer Cells
100%
Fatty Acids
31%
MDA-MB-231 Cells
13%
Paclitaxel Chemosensitivity
13%
T47D
9%
IC50
9%
Synergism
9%
Simultaneous Exposure
9%
Chemosensitivity
9%
Pre-incubation
9%
Combination Index Method
9%
Cellular Level
4%
Tumor Cells
4%
Cell Culture
4%
Vitamin E
4%
Drug Interactions
4%
Lipid Peroxidation
4%
Potentiation
4%
Cancer Chemotherapy
4%
MCF-7
4%
Antiproliferative Activity
4%
Additive Effect
4%
Additivity
4%
Inhibitory Concentration
4%
Oxidative Status
4%
Docosahexaenoic Acid
4%
Dietary Intervention
4%
In Vitro Cytotoxicity
4%
Eicosapentaenoic Acid
4%
α-linolenic Acid
4%
Cell Growth Inhibition
4%
Experimental Support
4%
Linoleic Acid
4%
Carcinoma Cell Lines
4%
MCF-7 Cells
4%
Isobologram
4%
Breast Carcinoma Cells
4%
Human Breast Carcinoma
4%
MTT Assay
4%
3-(4,5-dimethylthiazol-2-yl)-2
4%
Cytoxicity
4%
Isobologram Analysis
4%
5-diphenyltetrazolium Bromide
4%
Paclitaxel Sensitivity
4%
Effect Level
4%
Interaction Assessment
4%
Median-effect Principle
4%
Isobole
4%
Concurrent Exposure
4%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Paclitaxel
100%
Oleic Acid
100%
Gamma Linolenic Acid
100%
Cytotoxicity
100%
Fatty Acid
26%
Synergism
7%
IC50
7%
Breast Carcinoma
7%
Cancer Chemotherapy
3%
Cell Culture
3%
Neoplasm
3%
Drug Interaction
3%
Alpha Tocopherol
3%
Linolenic Acid
3%
Docosahexaenoic Acid
3%
Icosapentaenoic Acid
3%
Linoleic Acid
3%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
3%
Neuroscience
Cytotoxicity
100%
Paclitaxel
100%
Oleic Acid
100%
Gamma Linolenic Acid
100%
Fatty Acids
26%
Cell Line
11%
Vitamin E
3%
In Vitro
3%
Cell Culture
3%
Lipid Peroxidation
3%
Docosahexaenoic Acid
3%
Cell Growth
3%
Icosapentaenoic Acid
3%
Linoleic Acid
3%
Linolenic Acid
3%
MTT Assay
3%